FDA Inspection 1191583 — Versiti Blood Health, Inc.
The FDA completed an inspection of Versiti Blood Health, Inc. on Nov 17, 2022 in Carmel, IN. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 17, 2022
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Carmel, IN (United States)